Source: Annual Congress 2008 - Pulmonary vascular medicine
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Boutet, I. Frachon, Y. Jobic, C. Gut-Gobert, O. Sitbon, C. Leroyer, P. Le Mevel, G. Le Garff, D. Carlhant, G. Simonneau, M. Humbert (Clamart, Brest, France). Cardiovascular complications and norfenfluramine exposure with benfluorex use. Eur Respir J 2008; 32: Suppl. 52, 1582

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular events related to the use of varenicline Source: Annual Congress 2012 - Tobacco cessation Year: 2012 Cardiovascular adverse effects during itraconazole therapy Source: Eur Respir J 2008; 32: 240 Year: 2008 Fenfluramine-like cardiovascular side-effects of benfluorex Source: Eur Respir J 2009; 33: 684-688 Year: 2009 Pulmonary hypertension associated with benfluorex exposure Source: Eur Respir J 2012; 40: 1164-1172 Year: 2012 Cardiovascular complications and comorbidities in CAP Source: Eur Respir Monogr 2014; 63: 256-254 Year: 2014 Use of varenicline in the treatment of smokers with cardiovascular disease Source: Annual Congress 2013 –Smoking cessation Year: 2013 Cardiovascular side-effects of common antibiotics Source: Eur Respir Monogr 2020; 88: 264-278 Year: 2020 Pharmacokinetics and safety of concomitant macitentan and hormonal contraceptives Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Effectiveness of treatment with varenicline in smokers with cardiovascular diseases (CVD) Source: Annual Congress 2009 - Smoking cessation Year: 2009 Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017 COPD and concomitant arterial hypertension: The efficacy and safety of slow-release formulation of indapamide Source: International Congress 2014 – Clinical presentations Year: 2014 Risks of diabetes mellitus and hyperglycaemic adverse events in patients with COPD taking inhaled corticosteroids Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension Source: Eur Respir J 2013; 41: 872-878 Year: 2013 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Efficacy of diltiazem administration on the respiratory adverse effects of enalapril Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002 Acute health effects of short-term use of e-cigarette on respiratory and cardiovascular system Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) Year: 2018 Cardiovascular morbidity in OSA Source: Annual Congress 2003 - PG4 - Obstructive sleep apnoea - current pathophysiological, clinical and therapeutic concepts Year: 2003